生物活性 | |||
---|---|---|---|
描述 | β-catenin-IN-2, also known as compound H1B1, is a robust inhibitor of β-catenin, derived from patent US20150374662A1. It finds utility in colorectal cancer research[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.92mL 0.78mL 0.39mL |
19.59mL 3.92mL 1.96mL |
39.17mL 7.83mL 3.92mL |
参考文献 |
---|